Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ)
161.00 x 200 161.32 x 1,000
Post-market by (Cboe BZX)
161.02 -2.27 (-1.39%) 03/25/25 [NYSE]
161.00 x 200 161.32 x 1,000
Post-market 161.15 +0.13 (+0.08%) 19:46 ET
Profile for Tue, Mar 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Johnson & Johnson ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 USA

www.jnj.com Employees: 138,100 P: 732-524-0400

Sector:

Medical

Description:

Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.

Key Statistics

Overview:

Market Capitalization, $K 393,504,032
Enterprise Value, $K 400,050,048
Shares Outstanding, K 2,409,848
Annual Sales, $ 88,821 M
Annual Net Income, $ 14,066 M
Last Quarter Sales, $ 22,520 M
Last Quarter Net Income, $ 3,431 M
EBIT, $ 14,023 M
EBITDA, $ 21,362 M
60-Month Beta 0.47
% of Insider Shareholders 0.16%
% of Institutional Shareholders 69.55%
Float, K 2,405,992
% Float 99.84%
Short Volume Ratio 0.45

Growth:

1-Year Return 3.74%
3-Year Return -9.64%
5-Year Return 20.01%
5-Year Revenue Growth 8.24%
5-Year Earnings Growth 14.98%
5-Year Dividend Growth 30.93%

Per-Share Information:

Most Recent Earnings 2.04 on 01/22/25
Next Earnings Date 04/15/25 [BMO]
Earnings Per Share ttm 9.99
EPS Growth vs. Prev Qtr -15.70%
EPS Growth vs. Prev Year -10.92%
Annual Dividend Rate, $ 4.96
Annual Dividend Yield 3.04%
Most Recent Dividend 1.240 on 02/18/25
Next Ex-Dividends Date 02/18/25
Dividend Payable Date 03/04/25
Dividend Payout Ratio 48.76%
Most Recent Split 2-1 on 06/13/01

JNJ Ratios

Ratio
Price/Earnings ttm 16.38
Price/Earnings forward 15.46
Price/Earnings to Growth 2.63
Return-on-Equity % 34.24%
Return-on-Assets % 13.63%
Profit Margin % 15.84%
Debt/Equity 0.43
Price/Sales 4.44
Price/Cash Flow 12.47
Price/Book 5.51
Book Value/Share 29.69
Interest Coverage 23.10

JNJ Dividends

Date Value
02/18/25 $1.2400
11/26/24 $1.2400
08/27/24 $1.2400
05/20/24 $1.2400
02/16/24 $1.1900
11/20/23 $1.1900
08/25/23 $1.1900
05/22/23 $1.1900
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals